Form 4: Vericel Corp: CFO Sells Shares Under 10b5-1 Plan

Vericel Corp's Chief Financial Officer, Joseph Anthony Mara Jr., has sold 5,000 shares of common stock as part of a pre-arranged trading plan.

Summary

• Joseph Anthony Mara Jr., Chief Financial Officer of Vericel Corp (VCEL), reported a transaction on June 26, 2026.
• Mara sold 5,000 shares of common stock at a price of $44.75 per share.
• This sale was executed under a Rule 10b5-1 trading plan, adopted on December 2, 2025, which allows for automatic sales under specific conditions.
• Following this transaction, Mara beneficially owns 16,009 shares of Vericel Corp common stock.
• The filing also notes that some of Mara's shares were acquired through the Issuer's 2015 Employee Stock Purchase Plan, in transactions exempt from certain reporting requirements.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was conducted under a pre-arranged 10b5-1 plan, mitigating concerns about opportunistic trading.

Positives

• The sale was conducted under a Rule 10b5-1 plan, indicating pre-planned and potentially less market-sensitive execution.
• The reporting person still beneficially owns a significant number of shares (16,009) after the sale.
• Shares acquired through the Employee Stock Purchase Plan are noted as exempt, suggesting standard employee benefit participation.

Negatives

• A disposal of company stock by a key executive, even under a pre-arranged plan, can sometimes be perceived negatively by the market.
• The sale represents a reduction in the CFO's direct holdings.

Risks

• The Rule 10b5-1 plan itself is subject to market conditions and the specific parameters set within the plan.
• Future sales under the plan could continue to reduce the CFO's direct ownership.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance. It solely reports a past transaction by an insider.

Management Comments

• The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
• These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Industry Context

StockSavvy.ai notes that insider sales under Rule 10b5-1 plans are common in the biotechnology and medical device sectors, where executives may diversify holdings or manage personal finances while adhering to insider trading regulations.

Stakeholder Impact

• Shareholders: May observe the sale, but the 10b5-1 plan context suggests it's a pre-determined transaction rather than a reaction to negative company news.
• Employees: The mention of the Employee Stock Purchase Plan indicates ongoing employee benefit programs.
• Management: The transaction reflects standard financial management by an executive.

Next Steps

• Continued adherence to the Rule 10b5-1 trading plan for any future transactions.
• Monitoring of Vericel Corp's ongoing business operations and financial performance.

Key Dates

Keywords

Vericel Corp, VCEL, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Joseph Anthony Mara Jr, Chief Financial Officer, Beneficial Ownership, Employee Stock Purchase Plan